Patent counts are not product evidence.

BrainSignal does not currently publish a patent schedule sufficient for buyer diligence. The site therefore does not rely on a patent count as evidence of product capability, efficacy, security, or freedom to operate. Technical and operational claims should be evaluated through public source, reproducible receipts, and buyer-run pilots.

For a confidential intellectual-property diligence request, contact [email protected].